Shingles Vaccine Linked to Reduced Dementia Risk in Groundbreaking Study

A groundbreaking study reveals a significant link between the shingles vaccine Shingrix and a reduced risk of dementia. Analyzing over 200,000 medical records, researchers found that Shingrix recipients had a 17% lower dementia risk compared to those vaccinated with Zostavax. This research highlights the importance of shingles vaccination, especially for older adults, and suggests that Shingrix may also delay dementia onset. With implications for public health strategies, this study could reshape vaccination approaches to enhance cognitive health.